Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Autoimmune Disease in Pregnancy


Published on

Powerpoint presentation by Dr Max Mongelli on autoimmune disease in pregnancy

Published in: Health & Medicine
  • blood sugar has come down to normal range, I have lost excess weight, I have all kinds of energy and I don't take insulin anymore! ▲▲▲
    Are you sure you want to  Yes  No
    Your message goes here
  • Discover How Thousands of Men and Women Worldwide Have Already Used The Reverse Diabetes Today™ System To Lower Blood Sugar To Normal And Safely Reverse Their Type 2 Diabetes Without Drugs or Insulin. ▲▲▲
    Are you sure you want to  Yes  No
    Your message goes here
  • Semenax - Save up to 50% | Online Special Offer ➤➤
    Are you sure you want to  Yes  No
    Your message goes here

Autoimmune Disease in Pregnancy

  1. 1. AUTOIMMUNE DISEASES IN PREGNANCY Dr Max Mongelli Department of Obstetrics & Gynaecology Nepean Hospital University of Sydney
  2. 2. Autoimmune disorders: More common among pregnant women Abnormal antibodies can cross the placenta andaffect the fetus Pregnancy affects autoimmune diseases indifferent ways
  3. 3. Most common conditions: Thyroid Disease Crohn’s Disease SLE Myasthenia Gravis Immune Thrombocytopenic Purpura Rheumatoid Arthritis Pemphigoid Gestationis
  4. 4. Thyroid Disease in Pregnancy Graves’ Disease Hashimotos’ Disease
  5. 5. Graves’ Disease Hyperthyroidism Goitre Ophthalmopathy Pretibial myxedema Antibodies to TSH receptor
  6. 6. Hashimotos’ Thyroiditis “Chronic autoimmune thyroiditis” Most common cause of hypothyroidism Gradual thyroid failure or goitre Autoimmune destruction of thyroid gland Sex ratio 7:1 Antibodies against TG, TPO, TSH receptor
  7. 7. Diagnosis of Hyperthyroidism inPregnancy TSH < 0.01 Raised free T4 +/- raised free T3 Difficult to ascertain cause in pregnancy
  8. 8. Causes of Hyperthyroidism in Pregnancy Graves’ Disease Gestational Transient Thyrotoxicosis - HCGmediated Molar pregnancy Familial gestational thyrotoxicosis
  9. 9. Hyperthyroidism in Pregnancy Increased risk of - Miscarriage Premature labour Low birth weight Stillbirth Pre-eclampsia Heart failure
  10. 10. Hypothyroidism in Pregnancy Usually subclinical rather than overt PET and PIH Placental abruption Non-reassuring CTG Preterm delivery Increased risk of C/S PPH
  11. 11. Thyroid Peroxidase (TPO) Antibodies Increased risk of miscarriage Increased risk of preterm delivery 20% develop hypothyroidism if untreated Risks may be reduced by T4 therapy
  12. 12. T4 therapy in pregnancy: Hypothyroid women need more T4replacement As much as 50% dose increase Aim at normalising the TSH levels Important for normal fetal cognitivedevelopment
  13. 13. Postpartum Thyroiditis: Occurs in 5-10% of all pregnancies May occur after delivery or pregnancy loss May decrease milk volume Transient hyperthyroidism followed bytransient hypothyroidism May recur in subsequent pregnancies Risk may be reduced by seleniumsupplements
  14. 14. Crohn’s Disease
  15. 15. Crohn’s Disease: effect of pregnancy. Pregnancy has no effect on disease activity Perianal disease not worsened by vaginaldelivery Fistulas may occur during pregnancy Elective c/s controversial
  16. 16. Crohn’s Disease: effect on pregnancy. Increased risk of preterm delivery and IUGR Comparable to effect of moderate smoking Higher risk if disease active at conception Careful monitoring during pregnancy
  17. 17. Systemic Lupus Erythematosus
  18. 18. SLE features associated with high maternaland fetal risks – pregnancy relativelycontraindicated: Severe pulmonary hypertension Restrictive lung disease Heart failure History of severe HELLP or PET Stroke within previous 6/12 Lupus flare within previous 6/12
  19. 19. SLE complications in pregnancy: Disease exacerbation Miscarriage, stillbirth IUGR, preterm labour Neonatal lupus Drugs and breast-feeding
  20. 20. Neonatal Lupus: Occurs in up to 2% of mothers with SLE Targets skin and cardiac tissue,rarely other tissues Congenital partial or complete heart block Heart block detected in utero Complete heart block: PNM of 44% Rash: erythematous annular lesions Rash clears within 6/12 Maternal dexamethasone may prevent progressionof heart block Neonatal pacemaker if HR<55
  21. 21. Antiphospholipid antibodies Anti-cardiolipin Lupus anticoagulant Increased risk of miscarriage Risk may be reduced with aspirin +heparin
  22. 22. Investigations for SLE in pregnancy: Physical examination and BP FBC, renal function Anti-Ro/SSA abs and anti-La/SSB abs LA and aCL assays Anti-dsDNA abs Complement
  23. 23. Myasthenia Gravis
  24. 24. Myasthenia Gravis: Typically presents with fluctuating skeletalmuscular weakness May be ocular or generalised May have antibodies to the AChR 10-15% have a thymoma Respiratory muscle involvement may leadto respiratory failure
  25. 25. Myasthenia Gravis in Pregnancy: Pregnancy has a variable effect on thecourse of MG Post-partum exacerbations in 30% Infections can trigger exacerbations Steroids can cause transient worsening MgSO4 is contraindicated
  26. 26. Myasthenia Gravis – Effect on the Fetus Transplacental passage of IgG anti-AChR Neuromuscular junction disordersTransient neonatal MG in 10-20% Decreased FM’s and breathing Polyhydramnios Arthrogryposis multiplex congenita
  27. 27. Myasthenia Gravis – Labour & Delivery First stage of labour not affected Second stage: expulsive efforts mayweaken Assisted vaginal delivery may be indicated Pre-labour anaesthetic assessmentindicated
  28. 28. Immune Thrombocytopenic Purpura ITP
  29. 29. ITP – Diagnostic Criteria: Isolated thrombocytopenia No drugs or other conditions that mayaffect platelet count Exclude HIV, Hep C, SLE
  30. 30. ITP – Pathology: Increased platelet destruction Inhibition of platelet production atmegakaryocyte level Mediated by IgG Abs against plateletmembrane glycoproteins Usually a chronic condition
  31. 31. ITP – Clinical Features: Petechiae, purpura, easy bruising Epistaxis, menorrhagia, bleeding fromgums GIT bleeding, hematuria: rare Intracranial hemorrhage – very rare
  32. 32. ITP and Pregnancy May affect fetus in up to 15% of cases Neonatal count may drop sharply several days afterbirth Difficult to differentiate from gestationalthrombocytopenia Epidurals safe if count > 50000 Prednisone +/- IVIG if count < 50000 Manage delivery according to standard obstetricpractice Avoid NSAIDS post-partum
  33. 33. Gestational Thrombocytopenia Incidence about 5% Occurs late in pregnancy Mild (>70 000) No fetal neonatal thrombocytopenia Postpartum resolution
  34. 34. Rheumatoid Arthritis
  35. 35. Rheumatoid Arthritis in Pregnancy Affects 1-2% of the general population More common in women RA in pregnancy is a common challenge Sex hormones have effects on disease activity 70-80% of cases improve during pregnancy Post-partum flare common
  36. 36. Effect of Pregnancy on RA Minimal effects on fetal morbidity andmortality Steroids may increase risk of IUGR andPPROM Active disease correlates with lower birthweights
  37. 37. Treatment of RA in Pregnancy Avoid NSAIDS and high dose aspirin Low-dose aspirin safe Use lowest doses of prednisone Sulfasalazine, hydroxychloroquine inrefractory cases
  38. 38. RA Medications and Breast-feeding –Avoid: Aspirin Azathioprine Cyclosporin Cyclophosphamide Methotrexate Chlorambucil High dose prednisone
  39. 39. Pemphigoid Gestationis
  40. 40. Pemphigoid Gestationis Blistering disease associated with increased fetal risk Incidence 1:1700 to 1: 50000 pregnancies Associated with HLA-DR3 and HLA-DR4 Caused by IgG1 against basement membrane of skin Bullous pemphigoid antigen 2 Eosinophilic infiltration
  41. 41. Pemphigoid Gestationis – Fetal Risks Preterm delivery in 1/3 of cases SGA in 1/3 of cases Worse prognosis if onset in 1st or 2nd trimesters Neonatal pemphigoid in up to 10% Mild disease that resolves in weeks
  42. 42. Concluding Remarks For rare autoimmune diseases limited data toguide decision-making Occasionally antibodies found incidentallywithout any clinical features Indication for close monitoring rather thantreatment Notify pediatrician if neonatal morbidity is apossibility